The Mass Spectrometry Shared Facility is a shared resource for investigators in the Comprehensive Cancer Center. This Shared Facility has two PE-Biosystems/PE-Sciex mass spectrometers, a PE-Sciex API III triple quadrupole instrument and a Voyager Elite MALDI-TOF instrument. Both instruments were obtained using NIH/NCRR Shared Instrumentation Grants. The Shared Facility provides the following services to the Comprehensive Cancer Center investigators for their federally funded research: 1) support of drug metabolism- pharmacokinetics projects by the development of HPLC mass spectrometry-based drug analyses; 2) quality control assurance of peptides synthesized in the Peptide Synthesis and Analysis Shared Facility; 3) the determination, with high fidelity, of the molecular weights of macromolecules including proteins, oligonucleotides and carbohydrates; 4) identification and sequence analysis of peptides and modified peptides (e.g., phosphopeptides) isolated from biological matrices and from protease digestion of pure proteins; 5) development of high sensitivity methods for the separation and analysis of peptides, in particular those based on capillary electrophoresis-MS and-MSMS; 6) consultative support of individual investigators so that they modify their analytical methods in order to utilize the full benefits of mass spectrometry; and 7) provision of a teaching program in mass spectrometry, including a course for graduate students, postdoctoral fellows and faculty, and extramural speakers with expertise in particular areas of mass spectrometry. The staff of the Shared Facility consists of the Director and the operators of the two mass spectrometers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013148-29
Application #
6299983
Study Section
Project Start
2000-03-03
Project End
2001-02-28
Budget Start
Budget End
Support Year
29
Fiscal Year
2000
Total Cost
$195,927
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Jimenez, Rachel V; Wright, Tyler T; Jones, Nicholas R et al. (2018) C-Reactive Protein Impairs Dendritic Cell Development, Maturation, and Function: Implications for Peripheral Tolerance. Front Immunol 9:372
Engle, Staci E; Antonellis, Patrick J; Whitehouse, Logan S et al. (2018) A CreER mouse to study melanin concentrating hormone signaling in the developing brain. Genesis 56:e23217
Van Arsdale, Anne R; Arend, Rebecca C; Cossio, Maria J et al. (2018) Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma. Cancer Med 7:616-625
Kim, Harrison (2018) Modification of population based arterial input function to incorporate individual variation. Magn Reson Imaging 45:66-71
Leath 3rd, Charles A; Monk, Bradley J (2018) Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years. Gynecol Oncol 150:391-397
Park, Misun; Yoon, Young Sup (2018) Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes. Korean Circ J 48:974-988
Toboni, Michael D; Smith, Haller J; Bae, Sejong et al. (2018) Predictors of Unplanned Reoperation for Ovarian Cancer Patients From the National Surgical Quality Improvement Program Database. Int J Gynecol Cancer 28:1427-1431
Dionne-Odom, J Nicholas; Applebaum, Allison J; Ornstein, Katherine A et al. (2018) Participation and interest in support services among family caregivers of older adults with cancer. Psychooncology 27:969-976
Demark-Wahnefried, Wendy; Schmitz, Kathryn H; Alfano, Catherine M et al. (2018) Weight management and physical activity throughout the cancer care continuum. CA Cancer J Clin 68:64-89
Bandari, Shyam K; Purushothaman, Anurag; Ramani, Vishnu C et al. (2018) Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior. Matrix Biol 65:104-118

Showing the most recent 10 out of 747 publications